GlassScriptPhysician profile
Bethany Briggs
NPI 1407202450
$3,718.12
in general payments reported to CMS, 2019-2025
11 companies · $1,065 in 2025
The $1,065 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $15.53 · 2023: $1,469 · 2024: $1,169 · 2025: $1,065.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,900 · Travel and Lodging: $1,803.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,899.62 |
| Travel and Lodging | $1,802.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,290.22 | 2023-2025 | Vistaseal, Echelon Flex |
| W. L. Gore & Associates, INC. | $1,001.40 | 2024 | Gore Bio-A Tissue Reinforcement, Gore Enform Preperitoneal Biomaterial, Gore Synecor Biomaterial |
| Intuitive Surgical, INC. | $971.58 | 2023-2025 | Da Vinci Surgical System |
| Ethicon US, LLC | $167.29 | 2024 | N/A, Echelon Endopath, Stratafix |
| Reshape Lifesciences INC. | $121.39 | 2023 | |
| Medtronic, INC. | $47.41 | 2025 | Endoflip |
| Novo Nordisk INC | $30.55 | 2022-2023 | |
| Davol INC. | $28.49 | 2025 | Phasix Mesh |
| C. R. Bard, INC. & Subsidiaries | $27.70 | 2023 | Arista Ah Flexitip |
| Endo Pharmaceuticals INC. | $18.15 | 2023 | Nascobal |
| Smith+Nephew, INC. | $13.94 | 2025 | Grafix Pl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bethany Briggs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.